Acadian Asset Management »

Fulcrum Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $674k 189k 3.57
2021-03-31 $41k 3.5k 11.81
2020-09-30 $15k 1.9k 7.97

More positions owned by Acadian Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Check Point Software Tech Ord (CHKP)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Logitech Intl S A SHS (LOGI)
Colgate-Palmolive Company (CL)
Spotify Technology S A SHS (SPOT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
Cintas Corporation (CTAS)
Marsh & McLennan Companies (MMC)
Wix SHS (WIX)
NetApp (NTAP)

View all positions for Acadian Asset Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
BlackRock
BlackRock
Nantahala Capital Management
Caption Management
Vanguard Group
Suvretta Capital Management
Trv Gp Iv
Citadel Advisors
Perceptive Advisors
Logos Global Management
MPM Oncology Impact Management
Leucadia National Corporation
Dimensional Fund Advisors
Geode Capital Management

View all funds holding Fulcrum Therapeutics